{"cluster": 63, "subcluster": 7, "abstract_summ": "DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further.DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further.We demonstrate that hydroxychloroquine inhibits trained immunity at the functional and epigenetic level and is accompanied by profound changes in the cellular lipidome as well as reduced expression of interferon-stimulated genes.In the current COVID-19 pandemic, prioritizing the immunity enhancers is equally important to anti-virals.So, Consideration of aminoglycosides can be a double edge sword viz., against respiratory infection as well as Immunity enhancer (along with anti-virals) for COVID-19 regimen.", "title_summ": "Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?Hydroxychloroquine inhibits trained immunity - implications for COVID-19Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?Aminoglycosides can be a better choice over Macrolides in COVID-19 regimen: Plausible Mechanism for repurposing strategy", "title_abstract_phrases": "DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further.DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further.Our findings therefore suggest that hydroxychloroquine may not have a beneficial effect on the anti-viral immune response to SARS-CoV-2.Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?The SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19.We demonstrate that hydroxychloroquine inhibits trained immunity at the functional and epigenetic level and is accompanied by profound changes in the cellular lipidome as well as reduced expression of interferon-stimulated genes.We believe this is the first time DEC is being proposed to treat COVID-19.Hydroxychloroquine inhibits trained immunity - implications for COVID-19SARS-CoV-2 infection can cause severe disease for which currently no specific therapy is available."}